Dan Mendelson is the Chief Executive Officer of Morgan Health at JPMorgan Chase & Co. Mendelson oversees a business unit at JPMorgan Chase focused on accelerating the delivery of new care models that improve the quality, equity and affordability of employer-sponsored healthcare.Mendelson was previously Founder and CEO of Avalere Health, a healthcare advisory company based in Washington DC. He also served as Operating Partner at Welsh Carson, a private equity firm. Before founding Avalere, Mendelson served as associate director for Health at the Office of Management and Budget in the Clinton White House.
Mendelson currently serves on the boards of Vera Whole Health and Champions Oncology (CSBR). He is also an adjunct professor at the Georgetown University McDonough School of Business. He previously served on the boards of Coventry Healthcare, HMS Holdings, Pharmerica, Partners in Primary Care, Centrexion, and Audacious Inquiry. Mendelson holds a Bachelor of Arts (BA) from Oberlin College, and a Master of Public Policy (MPP) from the Kennedy School of Government at Harvard University.
Virgilio "V" Bento has devoted his career to revolutionizing healthcare with the power of artificial intelligence. It was a personal experience that ignited V's passion for revolutionizing healthcare. When his brother faced a challenging recovery after an accident, V was inspired to find a better solution. This led to the invention of the Digital Therapist, the world's first AI Care solution, during his PhD studies in Electrical Engineering. This innovative solution empowered patients to recover at home independently, overcoming limitations in access to care.
Following his PhD, V founded Sword Health and launched the world's first platform to predict, prevent, and treat pain. Matching Sword's AI therapists with the expertise of clinical teams, the Sword platform makes high-quality care accessible. V is listed on over 30 patents and has authored more than 40 research papers in fields diverse in sensor fusion algorithms, motion tracking systems, and neuroplasticity. Daring in design and cautious execution, V's path is shaped by his will to find new ways to free people from pain worldwide, knowing AI is his greatest ally.
The scaling power of AI can simultaneously remove barriers to access, drive costs down system-wide and elevate the role of the human clinician so they can focus on human touch that their patients need.